newsfilter
← Latest News
GlobeNewswire·

Improving access for patients: launch of Lisdexamfetamine further broadens Sandoz Canada portfolio

PrSandoz® Lisdexamfetamine, one of first generic equivalents of Vyvanse*, available on Canadian marketApproved for all indications of reference medicine: Attention Deficit Hyperactivity Disorder and Binge